13.03.2023 08:45:00

INVL Baltic Sea Growth Fund-backed Egles Sanatorija acquires a rehabilitation services company in Vilnius

Egles Sanatorija, a portfolio company of the INVL Baltic Sea Growth Fund, the leading private equity fund in the Baltic region, has acquired Reabilita.lt, a provider of rehabilitation services in the Lithuanian capital Vilnius. Until now Egles Sanatorija, which is the largest sanatorium treatment and medical rehabilitation centre in the Baltics, served customers only in Druskininkai and Birštonas.

"This is Egles Sanatorija’s first day centre, which will offer procedures long valued by the medical spa’s customers for their important effects on the health-recovery process. We want to be closer to our customers so that they can focus more on recovering and improving their health and can continue treatment they began in Birštonas or Druskininkai in Vilnius and vice versa,” says Arturas Salda, the Director General at Egles Sanatorija.

Nerijus Drobavicius, Partner at INVL Baltic Sea Growth Fund and Chairman of the Board of Egle Sanatorija, says that in the medical rehabilitation sector the focus will be on strengthening restorative medical treatment, medical and preventive rehabilitation. Access to these services is important as part of the overall health ecosystem.

A further EUR 100,000 of investment in equipment for the Egles Sanatorija day centre in Vilnius is planned.

The Vilnius-based provider of rehabilitation services is the first add-on investment following the acquisition of Namita and Egles Sanatorija at the end of 2022.

The INVL Baltic Sea Growth Fund, together with its co-investors, owns 100% of the shares of Namita, the company that owns Egles Sanatorija.

About INVL Baltic Sea Growth Fund

With a size of EUR 165 million, the INVL Baltic Sea Growth Fund is a leading equity fund in the Baltics. The European Investment Fund ("EIF”) is its anchor investor.

The EIF, which is a part of the European Investment Bank, has committed EUR 30 million with the support of the European Fund for Strategic Investments (a key element of the Investment Plan for Europe, or ‘Junker Plan’) whilst also allocating resources from the Baltic Innovation Fund, a "fund of funds” initiative developed in cooperation with the governments of Lithuania, Latvia and Estonia. The initiative aims to increase capital investment in high-growth potential small and medium-sized enterprises in the Baltics.

The fund seeks to assemble a diversified portfolio of companies, targeting majority or significant minority stakes through investments ranging from of EUR 10 million to EUR 30 million. These companies must demonstrate high growth potential and an ability to succeed in conditions of increasing global competition and market volatility.

The fund is focused on the Baltic countries and neighbouring regions including Poland, the Nordics, and Central Europe. The fund has invested in seven companies to date, focusing on sectors including healthcare, medical rehabilitation, civil engineering, environmental management (plastic recycling and waste management), veterinary services, and the manufacturing of cosmetics and hygiene products.

The fund is managed by INVL, the leading Baltic investment management and life insurance group. The group’s companies manage pension and mutual funds, life insurance directions, individual portfolios, private equity as well as other alternative investments. More than 300,000 clients in Lithuania, Latvia and Estonia plus international investors have entrusted the group with the management of over EUR 1.75 billion of assets. With a track record spanning 30 years, the group has strong expertise and experience in managing private equity assets and building true market players that are leaders in their respective fields in the Baltic countries and across Central and Eastern Europe.

Contact person for further information:
Nerijus Drobavicius, Partner at INVL Baltic Sea Growth Fund
E-mail: Nerijus.Drobavicius@invl.com

 


Nachrichten zu Invalda ABmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Invalda ABmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Invalda AB 17,60 2,92% Invalda AB